Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance.

PloS One
John KorenChad Dickey

Abstract

MKT-077, a rhodacyanine dye, was shown to produce cancer specific cell death. However, complications prevented the use of this compound beyond clinical trials. Here we describe YM-1, a derivative of MKT-077. We found that YM-1 was more cytotoxic and localized differently than MKT-077. YM-1 demonstrated this cytotoxicity across multiple cancer cell lines. This toxicity was limited to cancer cell lines; immortalized cell models were unaffected. Brief applications of YM-1 were found to be non-toxic. Brief treatment with YM-1 restored tamoxifen sensitivity to a refractory tamoxifen-resistant MCF7 cell model. This effect is potentially due to altered estrogen receptor alpha phosphorylation, an outcome precipitated by selective reductions in Akt levels (Akt/PKB). Thus, modifications to the rhodocyanine scaffold could potentially be made to improve efficacy and pharmacokinetic properties. Moreover, the impact on tamoxifen sensitivity could be a new utility for this compound family.

References

Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M J WeissL B Chen
Jan 23, 1998·Journal of Medicinal Chemistry·M KawakamiL B Chen
Oct 29, 1998·The Journal of Biological Chemistry·R WadhwaS C Kaul
Oct 6, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D J PropperA L Harris
Apr 30, 2004·Photochemistry and Photobiology·Dino GabrielliMauricio S Baptista
Feb 14, 2006·American Journal of Clinical Pathology·Andre M OliveiraJonathan A Fletcher
Nov 13, 2007·Advances in Experimental Medicine and Biology·Ana Maria Gonzalez-AnguloGabriel N Hortobagyi
Jan 29, 2008·Current Medicinal Chemistry·Eric BadiaVincent Cavaillès
Feb 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·Chad A DickeyLeonard Petrucelli
Oct 2, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Umesh K JinwalChad A Dickey
Oct 13, 2009·Molecular Cell·J I-Ju LeuDonna L George
Nov 6, 2009·The Journal of Biological Chemistry·John KorenChad A Dickey
Jan 22, 2011·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Iván P Uray, Powel H Brown
Feb 10, 2011·The Oncologist·Clifford A Hudis, Luca Gianni
May 27, 2011·Seminars in Oncology·Melody A Cobleigh
Jun 29, 2011·Journal of Molecular Biology·Aikaterini RousakiErik R P Zuiderweg
Oct 5, 2011·CA: a Cancer Journal for Clinicians·Carol DeSantisAhmedin Jemal

❮ Previous
Next ❯

Citations

Apr 9, 2013·Carcinogenesis·Maureen E Murphy
Jun 25, 2014·Expert Opinion on Therapeutic Targets·Håkon ReikvamØystein Bruserud
Feb 13, 2016·Cell Stress & Chaperones·Jürgen Radons
May 25, 2015·Journal of Molecular Biology·Kristoffer R Brandvold, Richard I Morimoto
Oct 28, 2014·Oncogene·M Y Sherman, V L Gabai
Sep 24, 2016·Molecular Neurobiology·Sara D ReisJorge M A Oliveira
Dec 29, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Umesh K JinwalChad A Dickey
Oct 17, 2014·Molecular Pharmacology·Makaía M PapasergiGregory G Tall
Aug 24, 2019·IUBMB Life·Reyhaneh Moradi-MarjanehMahdi Moradi Marjaneh
Sep 26, 2019·Cellular and Molecular Life Sciences : CMLS·Amanda K DavisYoichi Osawa
Jan 7, 2015·Journal of Materials Chemistry. B, Materials for Biology and Medicine·B N Prashanth KumarMahitosh Mandal
Jan 11, 2013·Molecular Cancer Research : MCR·Gregor M BalaburskiMaureen E Murphy
Oct 4, 2017·Molecular Cancer Research : MCR·Sharan R SrinivasanJason E Gestwicki
Dec 7, 2013·ACS Medicinal Chemistry Letters·Xiaokai LiJason E Gestwicki

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
ubiquitination

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.